当前位置: X-MOL首页全球导师 海外导师 › Spangler, Jamie

个人简介

PhD, Biological Engineering, Massachusetts Institute of Technology (2011) BS, Biomedical Engineering, Johns Hopkins University (2006)

研究领域

Prof. Spangler’s research aims to expand the repertoire of protein therapeutics by redesigning naturally occurring proteins and engineering new molecules to overcome the deficiencies of existing drugs. Integrating cutting-edge tools from structural biophysics, biomolecular engineering, and translational immunology, her research focuses on developing innovative platforms for the discovery and design of proteins that recruit novel mechanisms for disease therapy. In particular, Spangler’s group is interested in engineering antibody-based molecules that reshape immune cell behavior for targeted treatment of cancer, infectious diseases, and autoimmune disorders. The overarching goal of her interdisciplinary research program is to establish new insights into protein behavior and the extent to which it can be manipulated for medically relevant applications.

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

J.B. Spangler, J. Tomala, V.C. Luca, K.M. Jude, S. Dong, A.M. Ring, P. Votavova, M. Pepper, M. Kovar, K.C. Garcia. “Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms.” Immunity, 42(5):815-825, May 2015. J.B. Spangler, I. Moraga, J.L. Mendoza, K.C. Garcia. “Insights into cytokine-receptor interactions from cytokine engineering.” Annu Rev Immunol, 33:139-167, 2015. J.B. Spangler, M.T. Manzari, E.K. Rosalia, T. F. Chen, K.D. Wittrup. “Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression.” J Mol Biol, 422(4):532-544, Sep 2012. J.B. Spangler, J.R. Neil, S. Abramovitch, Y. Yarden, F. M. White, D. A. Lauffenburger, K.D. Wittrup. “Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling.” Proc Natl Acad Sci U S A, 107(30):13252-13257, Jul 2010.

推荐链接
down
wechat
bug